Screener
Encompass Health Corporation EHC Adjusted EBITDA
Discontinued — last reported Q1 '25
Segments
By segment
Other financials
Where this comes from
Reported directly by Encompass Health Corporation in its filing.
Tagged under the XBRL concept ehc:AdjustedEBITDA.
The source filing: Encompass Health Corporation’s 10-Q, filed May 1, 2025.
- Filed
- May 1, 2025
- Fiscal quarter
- Q1 FY2025
- Calendar quarter
- Q1 2025
- Accession
- 0000785161-25-000021
| Line item | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 |
|---|---|---|
| Adjusted EBITDA | $313.6 | $273.0 |
| Stock-based compensation | (9.5) | (9.3) |
| Depreciation and amortization | (79.2) | (70.3) |
| Loss on disposal or impairment of assets | (0.2) | (13.7) |
| Interest expense and amortization of debt discounts and fees | (31.8) | (35.2) |
| Net income attributable to noncontrolling interests | 45.0 | 26.3 |
| Change in fair market value of equity securities | 0.7 | 0.3 |
| Asset impairment impact on noncontrolling interests | — | 7.3 |
Item 1.Financial Statements (Unaudited)
FAQ
- What is Encompass Health Corporation's adjusted EBITDA?
- Encompass Health Corporation (EHC) reported adjusted EBITDA of $313.6M in Q1 2025.
- How has Encompass Health Corporation's adjusted EBITDA changed year-over-year?
- Encompass Health Corporation's adjusted EBITDA increased by 14.9% year-over-year, from $273M to $313.6M.
Ask your AI about Encompass Health Corporation's adjusted ebitda.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude